WWE spikes 10% as returning presumed executive chairman Vince McMahon announces plans for strategic alternatives; Costco up over 2% after December sales data Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER EARNINGS
- Aehr Test Systems (AEHR) up 15.5%
- Duck Creek Technologies (DCT) up 2.5%
ALSO HIGHER
- Spruce Biosciences (SPRB) up 96.0% after entering exclusive agreement for Tildacerfont with Kaken Pharma
- CytomX Therapeutics (CTMX) up 62.0% after entering strategic research collaboration with Moderna (MRNA)
- Emergent BioSolutions Inc. (EBS) up 12.7% after announcing $379.6M lotion contract for DoD
- WWE (WWE) up 10.2% after announcing plans for strategic alternatives under returning executive chairman Vince McMahon
- Sensus Healthcare (SRTS) up 10.2% after positive Q4 revenue pre-announcement
- Leonardo DRS (DRS) up 3.8% after securing U.S. Army contract for counter unmanned aircraft system
- Costco (COST) up 2.4% after December, Q4 sales data
DOWN AFTER EARNINGS
- Kura Sushi USA (KRUS) down 4.9%
ALSO LOWER
- Fate Therapeutics, Inc. (FATE) down 45.7% on termination of collaboration pact with Janssen
- Graphite Bio (GRPH) down 44.4% after announcing voluntary pause in its Phase 1/2 study of nulabeglogene autogedtemcel for sickle cell disease due to adverse event with patient
Symbols:
GRPH AEHR DCT SPRB CTMX MRNA WWE SRTS DRS COST - $450.26 /
-6.225 (-1.36%)
KRUS EBS FATE Keywords: fly intel, wall street, afterhours, movers, top stories, stocks